Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression

American Psychiatric Association, 1994 Berk, 1997, Acute phase proteins in major depression, J Psychosom Res, 43, 529, 10.1016/S0022-3999(97)00139-6 Blier, 1998, The use of pindolol to potentiate antidepressant medication, J Clin Psychiatry, 59, 16 Bodkin, 1997, Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy, J Clin Psychiatry, 58, 137, 10.4088/JCP.v58n0401 Bull, S.J., Huezo-Diaz, P., Binder, E.B., Cubells, J.F., Ranjith, G., Maddock, C., et al., Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry, in press. Chrousos, 1995, The hypothalamic–pituitary–adrenal axis and immune mediated inflammation, N Engl J Med, 332, 1351, 10.1056/NEJM199505183322008 Dentino, 1999, Association of interleukin-6 and other biological variables with depression in older people living in the community, Am J Geriatr Soc, 47, 6, 10.1111/j.1532-5415.1999.tb01894.x Dinan, 1997, Dexamethasone augmentation in treatment-resistant depression, Acta psychiatr Scand, 95, 58, 10.1111/j.1600-0447.1997.tb00374.x Duman, 2000, Neuronal plasticity and survival in mood disorders, Biol Psychiatry, 48, 732, 10.1016/S0006-3223(00)00935-5 Durman, 1997, A molecular and cellular theory of depression, Arch Gen Psychiatry, 54, 597, 10.1001/archpsyc.1997.01830190015002 Figurov, 2006, Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus, Nature, 381, 706, 10.1038/381706a0 Frommberger, 1997, Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission, Eur Arch Psychiatry Clin Neurosci, 247, 228, 10.1007/BF02900219 Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Harker, 2000, Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers, Blood, 95, 2514, 10.1182/blood.V95.8.2514 Hayley, 2005, The pathogenesis of clinical depression: stressor-and cytokine-induced alteration of neuroplasticity, Neuroscience, 135, 659, 10.1016/j.neuroscience.2005.03.051 Himmerich, 2008, Depression, comorbidities and the TNF-α system, Eur Psychiatry, 23, 421, 10.1016/j.eurpsy.2008.03.013 Hong, 2005, Interleukin-6 gene polymorphism and Chinese major depression, Neeuropsychobiol, 52, 202, 10.1159/000089003 Joffe, 1998, The use of thyroid supplements to augment antidepressant medication, J Clin Psychiatry, 59, 26 Kahl, 2006, Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder, Psychosom Med, 68, 669, 10.1097/01.psy.0000237858.76880.3d Kelsey, 1997, Switching drug class after initial SSRI failure, J Clin Psychiatry, 583, 26 Kronfol, 1999, Depression and immunity: the role of cytokines Kronfol, 2000, Cytokines and the brain implications for clinical psychiatry, Am J Psychiatry, 157, 683, 10.1176/appi.ajp.157.5.683 Lommatzsch, 2005, The impact of age, weight and gender on BDNF levels in human platelets and plasma, Neurobiol Aging, 26, 115, 10.1016/j.neurobiolaging.2004.03.002 Maes, 1995, Evidence for an immune response in major depression: a review and hypothesis, Prog Neuropsychopharmacol Biol Psychiatry, 19, 11, 10.1016/0278-5846(94)00101-M Maes, 1997, The immune pathophysiology of major depression, 197 Maes, 2002, Depressive and anxiety symptoms in the early peurperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation, Life Sci, 71, 1837, 10.1016/S0024-3205(02)01853-2 Marano, 2007, Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression, J Clin Psychiatry, 68, 512, 10.4088/JCP.v68n0404 Mastorakos, 1994, Hypothalamic–pituitary–adrenal axis activation and stimulation of systemic vaspressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion, J Clin Endocrinol Metab, 79, 934, 10.1210/jc.79.4.934 Mitoma, 2008, Stress at work alters serum brain-derived neurotrophic factor (BDNF) and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress ?, Prog Neuropsychopharmacol Biol Psychiatry, 32, 679, 10.1016/j.pnpbp.2007.11.011 Morikawa, 1998, Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter, Eur J Pharmacol, 349, 317, 10.1016/S0014-2999(98)00187-3 Mossner, 1998, Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interferon-6, Neurochem Int, 33, 251, 10.1016/S0197-0186(98)00026-6 Murphy, 2000, Reciprocal actions of interleukin-6 and brain derived neurotrophic factor on rat and mouse primary sensory neurons, Eur J Neurosci, 12, 1891, 10.1046/j.1460-9568.2000.00074.x Nemeroff, 2005, Use of atypical antipsychotics in refractory depression and anxiety, J Clin Psychiatry, 66, 13 O' Brien, 2004, Cytokines: abnormalities in major depression and implications for pharmacological treatment, Him Psychopharmacol, 19, 397, 10.1002/hup.609 O' Brien, 2007, Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy, J Psychiatr Res, 41, 326, 10.1016/j.jpsychires.2006.05.013 Podusto, 1996, Permeability at the blood-brain and blood nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF, Mol Brain Res, 36, 280, 10.1016/0169-328X(95)00250-V Roullion, 1998, The use of lithium augment antidepressant medication, J Clin Psychiatry, 59, 32 Sapolsky, 2000, Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders, Arch Gen Psychiatry, 57, 925, 10.1001/archpsyc.57.10.925 Schiepers, 2005, Cytokines and major depression, Prog Neuropsychopharmacol Biol Psychiatry, 29, 201, 10.1016/j.pnpbp.2004.11.003 Sen, 2008, Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analysis and implications, Biol Psychiatry, 64, 527, 10.1016/j.biopsych.2008.05.005 Sheehan, 1998, The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, 59, 34 Shelton, 2000, Cellular mechanisms in the vulnerability to depression and response to antidepressants, Psychiatr Clin North Am, 23, 713, 10.1016/S0193-953X(05)70193-3 Shoval, 2005, The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia, Eur Neuropsychopharmacol, 15, 319, 10.1016/j.euroneuro.2004.12.005 Sluzewka, 1996, Indications of immune activation in major depression, Psychiatry Res, 64, 161, 10.1016/S0165-1781(96)02783-7 Trivedi, 2006, STAR⁎D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR⁎D: implications for clinical practice, Am J Psychiatry, 163, 28, 10.1176/appi.ajp.163.1.28 Yoshimura, 2008, Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline, Hum Psychopharmacol, 23, 707, 10.1002/hup.979 Yoshimura, 2007, Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients, Prog Neuropsychopharmacol Biol Psychiatry, 31, 1034, 10.1016/j.pnpbp.2007.03.001 Zhu, 2006, The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters, Neuropsychopharmacol, 31, 2121, 10.1038/sj.npp.1301029